Control and challenge of COVID-19: lessons from China's experience.

Zhu, Na; Tan, Wenjie

Zhu, Na; Tan, Wenjie.

Zhu N; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing, China.
Tan W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing, China.

Am J Physiol Lung Cell Mol Physiol ; 321(5): L958-L959, 2021 11 01.

Article in English | MEDLINE | ID: covidwho-1526552

Subject(s)

COVID-19; China; Humans; SARS-CoV-2

Keywords

control; coronavirus disease 2019 (COVID-19); large-scale polymerase chain reaction (PCR)-based testing (LSPT); nonpharmaceutical interventions (NPIs); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Country/Region as subject: Asia Language: English Journal: Am J Physiol Lung Cell Mol Physiol Journal subject: Molecular Biology / Physiology Year: 2021 Document Type: Article Affiliation country: Ajplung.00412.2021

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google